NCT07380022

Acceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodphyte IB Defense and Goodphyte Immunity in Adults With Chronic Diseases.

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: University of Thessaly · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The primary objective of the present postdoctoral research is to evaluate the acceptability and adherence of two dietary supplements containing microbial phytase, Goodphyte IB Defense and Goodphyte Immunity, in adult individuals with chronic diseases, namely Idiopathic Inflammatory Bowel Diseases (IIBD)-that is, Crohn's disease (CD) or Ulcerative Colitis (UC)-Arterial Hypertension (AH), Anemia (AN), or Multiple Sclerosis (MS). Secondarily, this study will investigate potential changes in iron and zinc absorption following phytase supplementation in these individuals and, consequently, possible changes in their quality of life.

Conditions

• IBD
• Hypertension (HTN)
• Multiple Sclerosis
• Anemia
• Colitis Ulcerative

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Dietary supplement intervention Goodphyte IB Defense	Participants will receive orally Goodphyte IB Defense at a dose of four capsules per day for a duration of two weeks.
DIETARY_SUPPLEMENT	Dietary supplement intervention Goodphyte Immunity	Participants will receive orally Goodphyte IB Immunity at a dose of four capsules per day for a duration of two weeks.

Timeline

• Start date: 2025-07-09
• Primary completion: 2026-02-28
• Completion: 2026-02-28
• First posted: 2026-02-02
• Last updated: 2026-02-02

Locations

1 site across 1 country: Greece